Ticlopidine Hydrochloride
Who holds supplier records for Ticlopidine Hydrochloride? 8 organisations hold a current record for Ticlopidine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (4), Netherlands (1), India (1), France (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ticlopidine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ticlopidine-hydrochloride
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ticlopidine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- TAPI NL BVNetherlandsCEPActive DMF 11664 · latest filing Sept 1995
- CURIA ITALY SRLItaly Company GMP cert on recordActive DMF 12643 · latest filing Sept 1997
- SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRLItaly Company GMP cert on recordActive DMF 10492 · latest filing Sept 1993
- AARTI DRUGS LTDIndiaCEP Company GMP cert on recordInactive DMF 22355 · latest filing Dec 2008
- ERREGIERRE SPAItalyCEP Company GMP cert on recordInactive DMF 11968 · latest filing May 1996
- FranceCEP Company GMP cert on record
- Zhejiang Liaoyuan Pharmaceutical Co., Ltd.ChinaCEP
- S.I.M.S. S.R.L.ItalyCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Ticlopidine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI NL B.V. Amsterdam | NL | CEP 2001-379 - Rev 06 Ticlopidine hydrochloride | Jul 2025 | — |
| Sanofi Winthrop Industrie Gentilly | FR | CEP 2000-052 - Rev 03 Ticlopidine hydrochloride | Feb 2024 | — |
| AARTI DRUGS LIMITED Mumbai | IN | CEP 2002-116 - Rev 03 Ticlopidine hydrochloride | Oct 2023 | — |
| ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town | CN | R1-CEP 2004-109 - Rev 03 Ticlopidine hydrochloride | May 2021 | — |
| ERREGIERRE S.P.A. San Paolo D'Argon | IT | R1-CEP 1999-081 - Rev 02 Ticlopidine hydrochloride | Jul 2017 | — |
| S.I.M.S. S.R.L. Reggello | IT | R1-CEP 2002-106 - Rev 02 Ticlopidine hydrochloride | Feb 2015 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Ticlopidine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- SANOFI SYNTHELABO INCInactive DMF 7975, 9638 · filed Apr 1992
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Ticlopidine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1717).
Chemical identity
- IUPAC name
- 5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine;hydrochloride
- Canonical SMILES
- C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl
- InChIKey
- MTKNGOHFNXIVOS-UHFFFAOYSA-N
- Synonyms
- 4-C-32, 53-32C, Ipaton, NSC-759165, Ticlid, Ticlopidine hcl, Ticlopidine hydrochloride, Tiklid, Panaldine, Ticlodix, Ticlodone, CHEBI:9589
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ticlopidine Hydrochloride?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Ticlopidine Hydrochloride: TAPI NL BV (Netherlands), CURIA ITALY SRL (Italy), SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (Italy), AARTI DRUGS LTD (India), ERREGIERRE SPA (Italy), Sanofi Winthrop Industrie (France), Zhejiang Liaoyuan Pharmaceutical Co., Ltd. (China) and S.I.M.S. S.R.L. (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ticlopidine Hydrochloride Drug Master Files are active?
TAPI NL BV (DMF 11664), CURIA ITALY SRL (DMF 12643) and SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (DMF 10492). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ticlopidine Hydrochloride records mean?
1 organisation has only inactive Type II DMFs for Ticlopidine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Ticlopidine Hydrochloride have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Ticlopidine Hydrochloride on the EDQM register, including TAPI NL B.V. Amsterdam (NL), Sanofi Winthrop Industrie Gentilly (FR), AARTI DRUGS LIMITED Mumbai (IN), ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town (CN), ERREGIERRE S.P.A. San Paolo D'Argon (IT) and S.I.M.S. S.R.L. Reggello (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ticlopidine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ticlopidine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.